UK markets closed

NOTV Jun 2024 2.500 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
0.0600-0.1600 (-72.73%)
As of 02:13PM EDT. Market open.
Full screen
Previous close0.2200
Open0.0600
Bid0.0000
Ask0.1000
Strike2.50
Expiry date2024-06-21
Day's range0.0600 - 0.0600
Contract rangeN/A
Volume2
Open interest285
  • GlobeNewswire

    Inotiv, Inc. Provides Business Updates

    WEST LAFAYETTE, Ind., June 10, 2024 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, today provided the following business updates: Hillcrest, U.K. expansion project completedExtension of the maturity date of the $3.7 million OBRC payable note to July 2025 Robert Leasure Jr., President and Ch

  • Associated Press Finance

    Company that bred beagles for research pleads guilty to neglect, ordered to pay record $35M fine

    A company that bred beagles for medical research agreed Monday to pay a record $35 million as part of a criminal plea admitting it neglected thousands of dogs at its breeding facility in rural Virginia. The plea deal also bars the company that operated the facility, Envigo RMS, as well as parent company Inotiv, from breeding or selling dogs in the future. The federal investigation of Envigo drew national attention in May 2022 when federal authorities conducted a search of the breeding facility in Cumberland County, Virginia, and found nearly 450 animals in acute distress.

  • GlobeNewswire

    Inotiv Reaches Agreement to Resolve Previously-Announced Investigation into Shuttered Cumberland Facility

    Company reaffirms commitment to maintaining appropriate standards of animal welfareWEST LAFAYETTE, Ind., June 03, 2024 (GLOBE NEWSWIRE) -- Inotiv Inc. – Inotiv Inc. (“Inotiv” or the “Company”) (Nasdaq: NOTV), a leading contract research organization dedicated to providing nonclinical and analytical drug discovery and development services and research models, today announced that it reached an agreement with the U.S. Department of Justice (“DOJ”) to resolve a previously-announced criminal investi